Parallel Advisors’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History
Bought
Maintained
Sold
Other funds holding AMYT
ACM
SCM
MAM
TAL
AAM
RSCM
Parallel Advisors's AMYT Position: Q1 2023 in Review
Parallel Advisors sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 68,524 shares — an estimated $500K sold.
Parallel Advisors first reported a position in AMYT in Q1 2022 and held it in 4 quarters. The position peaked at $604K in Q1 2022. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.
- Parallel Advisors reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
- Parallel Advisors sold 68,524 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $500K.
- Parallel Advisors first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2022 and held it in 4 quarters.
- Parallel Advisors's Amryt Pharma plc American Depositary Shares position peaked at $604K in Q1 2022.
- 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.
Based on Parallel Advisors's 13F filing for Q1 2023, filed 25 Apr 2023.